Iams Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-38,958
Closed -$2.96M 174
2023
Q2
$2.96M Buy
+38,958
New +$3.11M 1.08% 31

Other funds holding GILD

Iams Wealth Management's GILD Position: Q2 2026 in Review

Iams Wealth Management increased its Gilead Sciences (GILD) stake by 18% in Q2 2026, buying an estimated $498K and bringing the position to 25,186 shares worth $3.18M. The position accounts for 0.96% of the portfolio, ranked #30.

Iams Wealth Management first reported a position in GILD in Q4 2022 and has held it in 14 quarters since. 836 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Iams Wealth Management held 25,186 shares of Gilead Sciences worth $3.18M as of Q2 2026.
  • Iams Wealth Management bought 3,780 Gilead Sciences shares in Q2 2026, an estimated $498K.
  • Gilead Sciences made up 0.96% of Iams Wealth Management's portfolio in Q2 2026, its #30 holding.
  • Iams Wealth Management first reported a position in Gilead Sciences in Q4 2022 and has held it in 14 quarters since.
  • 836 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Iams Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.